Microalbuminuria in non-insulin-dependent diabetes
Related Experiment Videos
C E Mogensen1, E M Damsgaard, A Frøland
1Medical Department M, Diabetes and Endocrinology, Kommunehospital, Aarhus, Denmark.
Abstract:
According to international consensus, microalbuminuria is defined as an elevated urinary albumin excretion rate (UAER) of 20-200 micrograms/min, which is below the proteinuric range. Nephropathy is a major complication in IDDM, seen in about 30% of patients after many years of diabetes. Increasing microalbuminuria is an excellent marker of subsequent nephropathy in these patients. End-stage diabetic nephropathy is also important in NIDDM, but in most Western countries this serious complication eventually develops in only 5 to 10% of cases, whereas the majority of patients die before this from cardiovascular disease. In completely healthy individuals there is no clear correlation between age and UAER, at least up to about 70 years of age. The mean excretion rate is around 5 micrograms/min, with a considerable range, but excretion only rarely exceeds 15 micrograms/min. In population studies among middle-aged and elderly individuals, higher values are seen. In newly diagnosed NIDDM about 40% of patients show an excretion rate above 15-20 micrograms/min. There is a significant but not precise correlation between albumin excretion rate and glycemic control, and usually UAER is reduced by standard antidiabetic treatment. In a considerable number of patients, high values cannot be reduced. In the course of NIDDM about 20-30% of patients show microalbuminuria. In patients with known diabetes, microalbuminuria is related not only to subsequent diabetic proteinuria, but even more strongly to early death, mainly from cardiovascular disease. Even slight microalbuminuria (15-40 mg/l in early morning urines) is clearly associated with increased mortality. In subjects with newly detected elevated blood glucose (by screening) microalbuminuria also predicts early mortality. The mechanisms are not established, but several arteriosclerosis-related risk factors are seen more frequently in patients with microalbuminuria, e.g. lipid abnormalities, elevated systolic blood pressure (BP), hemostatic measures, as well other markers of cardiovascular disease. Usually there is a significant but not precise correlation between BP and UAER in groups of patients throughout the course of diabetes. New studies document that also in the elderly background population microalbuminuria is a significant risk factor for early death, maybe even stronger than the established risk markers, which thus may be confounded with the presence of microalbuminuria.
Insights
Microalbuminuria, an early sign of kidney damage in diabetes, is a strong predictor of cardiovascular disease and early death. Monitoring urinary albumin excretion rate (UAER) is crucial for risk assessment in diabetic patients.
Area of Science:
- Nephrology
- Diabetology
- Cardiovascular Medicine
Background:
- Microalbuminuria, defined as urinary albumin excretion rate (UAER) of 20-200 µg/min, is a key complication in diabetes mellitus (DM).
- Diabetic nephropathy affects ~30% of IDDM patients and 5-10% of NIDDM patients, with cardiovascular disease being the primary cause of mortality in NIDDM.
- Elevated UAER is observed in ~40% of newly diagnosed NIDDM patients and 20-30% of NIDDM patients during the disease course.
Purpose of the Study:
- To investigate the significance of microalbuminuria as a marker for diabetic nephropathy and mortality.
- To explore the correlation between UAER, glycemic control, and blood pressure in diabetic patients.
- To assess the role of microalbuminuria as a risk factor for early death in the general elderly population.
Main Methods:
- Review of international consensus definitions and epidemiological data on microalbuminuria (UAER).
- Analysis of correlations between UAER, age, glycemic control, and blood pressure (BP) in diabetic and non-diabetic populations.
- Evaluation of microalbuminuria as a predictor of nephropathy and mortality in patients with known and newly detected diabetes, as well as in the elderly population.
Main Results:
- Microalbuminuria is an excellent marker for subsequent nephropathy in IDDM and a strong predictor of early death, primarily from cardiovascular disease, in both IDDM and NIDDM.
- While UAER correlates with glycemic control and BP, standard antidiabetic treatment does not always reduce high UAER values.
- Even slight microalbuminuria (15-40 mg/l) is associated with increased mortality, and it is a significant risk factor for early death in the elderly, potentially confounding established risk markers.
Conclusions:
- Microalbuminuria is a critical indicator of diabetic kidney disease and a potent predictor of premature mortality, particularly cardiovascular death.
- Early detection and management of microalbuminuria are essential for risk stratification and intervention in diabetic patients and the elderly.
- Further research is needed to elucidate the mechanisms linking microalbuminuria to cardiovascular risk and early mortality.